Didier Carrié

Active 1990–2025

92
Papers
18,196
Citations
61
h-index
90
i10-index

Citations

Citations per year for Didier Carrié1972: 1 citations1993: 5 citations1994: 3 citations1995: 1 citations1996: 1 citations1997: 4 citations1998: 3 citations1999: 11 citations2000: 12 citations2001: 8 citations2002: 18 citations2003: 22 citations2004: 17 citations2005: 26 citations2006: 29 citations2007: 42 citations2008: 35 citations2009: 40 citations2010: 67 citations2011: 77 citations2012: 108 citations2013: 132 citations2014: 148 citations2015: 143 citations2016: 141 citations2017: 123 citations2018: 114 citations2019: 437 citations2020: 490 citations2021: 472 citations2022: 357 citations2023: 240 citations2024: 383 citations2025: 158 citations2026: 7 citations1973–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,353 citing papers, 17.3% of this breakdownItaly: 685 citing papers, 8.8% of this breakdownUnited Kingdom: 564 citing papers, 7.2% of this breakdownGermany: 551 citing papers, 7.1% of this breakdownFrance: 516 citing papers, 6.6% of this breakdownNetherlands: 429 citing papers, 5.5% of this breakdownCanada: 363 citing papers, 4.7% of this breakdownSwitzerland: 327 citing papers, 4.2% of this breakdownSpain: 283 citing papers, 3.6% of this breakdownJapan: 242 citing papers, 3.1% of this breakdownChina: 223 citing papers, 2.9% of this breakdownBelgium: 205 citing papers, 2.6% of this breakdown
0%17.3%Other 26.4%

Fields

  • Medicine89.7%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Chemical Engineering1.7%
  • Engineering0.7%
  • Immunology and Microbiology0.7%
  • Materials Science0.7%
  • Other1.3%

Topics

  • Coronary Interventions and Diagnostics11.7%
  • Cardiac Valve Diseases and Treatments10.7%
  • Antiplatelet Therapy and Cardiovascular Diseases6.5%
  • Acute Myocardial Infarction Research6.1%
  • Cardiac Imaging and Diagnostics5.7%
  • Cardiovascular Function and Risk Factors4.8%
  • Other54.5%

Coauthors

All papers

Open in search
  1. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 1,754

  2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Anderson, Rick Andreae, Michaël Angioı̈, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Edouard Benit, Olivier F. Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Paweł Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrié, Ángel Cequier, Ply Chichareon, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Éric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Géza Fontos, José Francisco Díaz Fernández, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, G. Gałuszka, Vasco Gama Ribeiro, Scot Garg, Giuseppe Gargiulo, Tobias Geisler, Валери Гелев, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Felice Gragnano, Ana Guimarães, Christian W. Hamm, Michael Haude, Dik Heg, Pieter Heijke, Rosa Ana Hernández Antolín, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd H. Hofma, Lene Holmvang, Stephen P. Hoole, Iván Horváth, Kurt Huber and 103 more - The Lancet 2018 cited by 785

  3. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2021 cited by 239

  4. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 808

  5. Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 cited by 130

  6. Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Éric Vicaut, Gilles Montalescot - The Lancet 2016 cited by 372

  7. European expert consensus on rotational atherectomy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - EuroIntervention 2015 cited by 355

  8. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality

    Authors: , , , , , , , , , , , , , - Amyloid 2019 cited by 120

  9. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 390

  10. Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephane Delpine, Géraud Souteyrand, Xavier Favereau, Patrick Ohlmann, Vincent Doisy, Gilles Grollier, Antoine Gommeaux, Jean-Philippe Claudel, F Bourlon, Bernard Bertrand, Éric Van Belle, Marc Laskar - New England Journal of Medicine 2012 cited by 1,227

  11. TAVR Patients Requiring Anticoagulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Favereau, Géraud Souteyrand, Patrick Ohlmann, Vincent Doisy, Farzin Beygui, Antoine Gommeaux, Jean-Philippe Claudel, F Bourlon, Bernard Bertrand, Bernard Iung, Martine Gilard - JACC: Cardiovascular Interventions 2021 cited by 68

  12. Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 877

  13. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 538

  14. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean François Obadia - European Journal of Heart Failure 2019 cited by 227

  15. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gert Richardt, Ariel Roguin, Chaim Lotan, Ran Kornowski, Patrizia Presbitero, Whady Hueb, J. Eduardo Sousa, Jorge Guillermo Velásquez, Alfredo E. Rodríguez, Gerry Devlin, J. French, Upendra Kaul - Journal of the American College of Cardiology 2018 cited by 259

  16. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Géraud Souteyrand, Patrick Ohlmann, Vincent Doisy, Thérèse Lognoné, Antoine Gommeaux, Jean-Philippe Claudel, F Bourlon, Bernard Bertrand, Bernard Iung, Martine Gilard - Circulation 2018 cited by 154

  17. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gérard HELFT, C. Lefeuvre, R. Choussat, Marie Hauguel, Michel Zeitouni, Thomas Cuisset, Jean-Louis Bonnet, Pierre Deharo, Benoît Lattuca, Guillaume Cayla, Luc Cornillet, Bertrand Ledermann, Clément Lonjon, Laurent Schmutz, Grégoire Rangé, Franck Albert, Thibault Demicheli, Laurent Roussel, R. Bensaid, Christophe Thuaire, Jean-Guillaume DILLINGER, Patrick Henry, Stéphane Manzo‐Silberman, Georgios SIDERIS, Damien Logeart, Vincent Spagnoli, Léa CACOUB, Christophe Pouillot, Jean Richard VI-FANE, Jens Glasenapp, K. Bougrini, Nicolas Combaret, Pascal Motreff, Géraud Souteyrand, Aimé Amonchot, Thomas Mouyen, Thibault Lhermusier, Didier Carrié, Frédéric Bouisset, Thomas Chollet, Francisco CAMPELO-PARADA, Nicolas Delarche, François Schiele, Mathieu BESUTTI, Marie Hauguel‐Moreau, Rami EL MAHMOUD, Christophe Caussin, Mami ZOHEIR, Aurélie Veugeois, Alain Dibié, Olivier Varenne, Fabien Picard, A. Lafont, Julien Adjedj, Philippe Degrell, Farzin Beygui, Rémi Sabatier, Vincent Roule, M Bignon, Katrien Blanchart, P Ardouin, Adrien Lemaître, Clément Briet, Ziad Boueri, Pascal Goube, Pierre Coste, Laura Cetran, Jérôme Clerc, Hervé Breton, Dominique Boulmier and 112 more - The Lancet 2020 cited by 130

  18. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2014 cited by 560

  19. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Didier Carrié, Jennifer Corbelli, Pierre Coste, Robbert de Winter, Abbey Diaz, S Eisenberg, Bruce W. Ennis, Jean Fajadet, Neil Fam, David Fortuin, C. Gessler, Cindy L. Grines, Diego de Sousa Guerra, H. Gum, Thomas Haldis, Ton Heestermans, Jean-Paul Herrman, T. Huynh, Elvin Kedhi, Michael J. Koren, Simon Kouz, Merrill Krolick, Gregory Kumkumian, Shahar Lavi, Ruijie Li, Arif Masud, Christopher McAlhany, Frank McGrew, Charles O’Shaughnessy, A. J. M. Oude Ophuis, Kirk Parr, William F. Penny, Yves Pesant, H. Post, Stuart Robinson, Josep Rodés‐Cabau, Andrew K. Roy, Sam Schulman, Fiona Spence, George A. Stouffer, Tomasz Styŝ, B. Sussex, Naeem Tahirkheli, Jean‐Claude Tardif, Jean Grégoire, Jurriën M. ten Berg, Ad J. van Boven, Clemens von Birgelen, Douglas Weinstein, Clemens von Birgelen, Douglas Weinstein - European Heart Journal 2014 cited by 252

  20. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy

    Authors: , , , , , , , , , , , , , , , - International journal of cardiac imaging 2016 cited by 87

  21. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean Armengaud, Patrick Dupouy, Didier Champagnac, Patrick Ohlmann, Knut Endresen, Hakim Benamer, Róbert Gábor Kiss, Imre Ungi, J Boschat, Marie‐Claude Morice - Journal of the American College of Cardiology 2014 cited by 354

  22. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2014 cited by 300

  23. Plaque rupture and morphological characteristics of the culprit lesion in acute coronary syndromes without significant angiographic lesion: Analysis by intravascular ultrasound

    Authors: , , , , , , - Annales de Cardiologie et d Angéiologie 2011 cited by 106

  24. Coronary artery aneurysm: A review

    Authors: , , , , , - World Journal of Cardiology 2021 cited by 70